Статус: | Completed |
Фаза: | Phase 3 |
Начало: | 15 декабря 2020 г. |
Окончание: | 27 июля 2023 г. |
Описание: | Objective: to evaluate the efficacy and safety of the Recombinant Non-immunogenic Staphylokinase with its single bolus administration in comparison with the bolus-infusion administration of the Alteplase in patients with massive pulmonary embolism |
смотреть на ClinicalTrials.gov |